DiaMedica Therapeutics
(NASDAQ) DMAC
DiaMedica Therapeutics Financials at a Glance
Market Cap
$326.53M
Revenue (TTM)
$0.00
Net Income (TTM)
$35.10M
EPS (TTM)
$-0.71
P/E Ratio
-8.59
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$5.67
Volume
78,332
Open
$6.02
Price
$5.67
Volume
78,332
Open
$6.02
Previous Close
$5.67
Daily Range
$5.63 - $6.02
52-Week Range
$3.48 - $10.42
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$5.67
Volume
78,332
Open
$6.02
Previous Close
$5.67
Daily Range
$5.63 - $6.02
52-Week Range
$3.48 - $10.42
DMAC News
DMAC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout DiaMedica Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
35
CEO
Rick John Pauls, MBA
Website
www.diamedica.comHeadquarters
Minneapolis, MN 55447, US
DMAC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-86%
Return on Capital
-78%
Return on Assets
-66%
Earnings Yield
-11.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$326.53M
Shares Outstanding
53.88M
Volume
78.33K
Avg. Volume
194.65K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$34.40M
EBITDA
$34.35M
Operating Cash Flow
$29.06M
Capital Expenditure
$40.00K
Free Cash Flow
$29.10M
Cash & ST Invst.
$59.89M
Total Debt
$240.00K
DiaMedica Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$11.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$326.53M
N/A
Market Cap/Employee
$12.09M
N/A
Employees
27
N/A
Net Income
$10.04M
-30.3%
EBITDA
$10.47M
-28.7%
Quarterly Fundamentals
Net Cash
$51.12M
+42.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$97.00K
-54.0%
Short Term Debt
$115.00K
+9.5%
Return on Assets
-66.13%
N/A
Return on Invested Capital
-77.61%
N/A
Free Cash Flow
$9.09M
-26.9%
Operating Cash Flow
$9.08M
-27.0%